首页 | 本学科首页   官方微博 | 高级检索  
     检索      


In vitro and in vivo bioactivity of recombinant canine hepatocyte growth factor
Authors:Arends Brigitte  Spee Bart  Hoffmann Gaby  Jansen Georgina E G  Slump Estel  Auriemma Edoardo  Ijzer Jooske  Hemrika Wieger  Romijn Roland A  van der Heijden-Liefkens Karin H A  Sondermeijer Paul J A  van den Ingh Ted S G A M  Penning Louis C  Rothuizen Jan
Institution:Faculty of Veterinary Medicine, Department of Clinical Sciences of Companion Animals, Utrecht University, Yalelaan 104, 3584 CM Utrecht, the Netherlands.
Abstract:Hepatocyte growth factor (HGF) is crucial for the development and regeneration of the liver and offers a possible new therapeutic strategy for the treatment of canine liver disease. In this study, the in vitro and in vivo bioactivity of recombinant canine HGF (rcHGF) produced with a baculoviral expression system in insect cells was measured. In vitro rcHGF induced mitogenesis, motogenesis, and phosphorylated the HGF receptor c-MET and its downstream mediators PKB and ERK1/2 in two canine epithelial cell lines. After a partial hepatectomy (phx) in dogs, rcHGF increased phosphorylation of c-MET, PKB and ERK1/2. A moderate increase was seen with the cell cycle protein PCNA in rcHGF treated livers, but no HGF-induced increase in liver weight was seen 7 days after phx. Furthermore, rcHGF treated livers showed lower levels of the key mediator of apoptosis, caspase-3, at 7days after phx. It is concluded that rcHGF is a biologically active protein in vitro and in vivo and the baculoviral expression system supplies sufficient amounts of rcHGF for future clinical studies in dogs.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号